Intermediate Capital Group (ICG) is heading to a final close on its latest secondaries and direct lending funds in FY23, while it considers launching new strategies for life sciences and North American private equity, the firm said in its FY22 report.
Latest co-mingled vehicle is around a third larger than previous two programmes in the series
Deal with MidEuropa sealed after auction for ophthalmology group went quiet earlier this month
Vendor Horizon collected offers for the agricultural information services provider last week
Multi-family office will doubling down on manager selectivity, opportunities in secondaries, and family offices' interest in increasing PE exposure